As of 2025-06-20, the Intrinsic Value of Cardinal Health Inc (CAH) is 1,695.84 USD. This CAH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 165.40 USD, the upside of Cardinal Health Inc is 925.30%.
The range of the Intrinsic Value is 1,112.34 - 3,700.40 USD
Based on its market price of 165.40 USD and our intrinsic valuation, Cardinal Health Inc (CAH) is undervalued by 925.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 1,112.34 - 3,700.40 | 1,695.84 | 925.3% |
| DCF (Growth 10y) | 1,528.66 - 4,779.60 | 2,265.03 | 1269.4% |
| DCF (EBITDA 5y) | 568.17 - 912.73 | 738.24 | 346.3% |
| DCF (EBITDA 10y) | 902.87 - 1,372.93 | 1,127.50 | 581.7% |
| Fair Value | 32.64 - 32.64 | 32.64 | -80.27% |
| P/E | 119.59 - 255.68 | 189.11 | 14.3% |
| EV/EBITDA | 60.45 - 305.48 | 184.70 | 11.7% |
| EPV | 94.40 - 125.96 | 110.18 | -33.4% |
| DDM - Stable | 82.52 - 331.25 | 206.88 | 25.1% |
| DDM - Multi | 860.06 - 2,610.95 | 1,285.28 | 677.1% |
| Market Cap (mil) | 39,477.67 |
| Beta | 0.50 |
| Outstanding shares (mil) | 238.68 |
| Enterprise Value (mil) | 43,830.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.66% |
| Cost of Debt | 4.28% |
| WACC | 6.21% |